Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1643, 2008-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ramipril, rosiglitazone for atherosclerosis: STARR results?
Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. :
Access to resources
Recommend
Rosiglitazone and MI risk - will we ever know the answer?
Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. :
Rosiglitazone: novel therapy for ulcerative colitis?
Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. :
Rosiglitazone an effective therapy for Cushing syndrome?
Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. :
Hepatotoxicity in patients taking rosiglitazone: is it drug-induced?
Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. :